Back to Search
JOANNE GEE, PHARMD
PHARMD
Pharmacist
NPI: 1790067114Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PH233248(MA)
Research & Publications (20)
Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival.
PMID 18825690·J Pathol·2009
8-other
Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin.
PMID 19007364·BJU Int·2009
8-other
Deciphering antihormone-induced compensatory mechanisms in breast cancer and their therapeutic implications.
PMID 17259561·Endocr Relat Cancer·2006
6-review
The Brucella abortus Cu,Zn superoxide dismutase is required for optimal resistance to oxidative killing by murine macrophages and wild-type virulence in experimentally infected mice.
PMID 15845493·Infect Immun·2005
7-preclinical
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer.
PMID 16113104·Endocr Relat Cancer·2005
6-review
Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitro models.
PMID 16168136·Breast Cancer Res·2005
8-other
Posthatch methoxychlor exposure adversely affects reproduction of adult zebra finches, Taeniopygia guttata.
PMID 15389323·Bull Environ Contam Toxicol·2004
7-preclinical
Extreme growth factor signalling can promote oestrogen receptor-alpha loss: therapeutic implications in breast cancer.
PMID 15217488·Breast Cancer Res·2004
8-other
Alzheimer's disease and frontotemporal dementia exhibit distinct atrophy-behavior correlates: a computer-assisted imaging study.
PMID 14697007·Acad Radiol·2003
8-other
Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization.
PMID 12793892·Breast Cancer Res·2003
6-review
The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro.
PMID 12960029·Endocrinology·2003
8-other
Characterization of regional pulmonary mechanics from serial magnetic resonance imaging data.
PMID 14587632·Acad Radiol·2003
8-other
Chaperone-mediated destruction of erbB2: relevance to tyrosine kinase inhibitors.
PMID 12238488·Breast Cancer Res·2002
6-review
Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer.
PMID 11400118·Int J Cancer·2001
8-other
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.
PMID 19238537·Breast Cancer Res Treat·2010
8-other
Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance.
PMID 19288272·Breast Cancer Res Treat·2010
8-other
Early parental care is important for hippocampal maturation: evidence from brain morphology in humans.
PMID 19595774·Neuroimage·2010
8-other
Appearance and incomplete label matching for diffeomorphic template based hippocampus segmentation.
PMID 19437413·Hippocampus·2009
8-other
Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the LipL32 gene.
PMID 19395218·Diagn Microbiol Infect Dis·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1603 WASHINGTON ST
BOSTON, MA 02118 - Phone
- (617) 267-5109
Quick Facts
- NPI
- 1790067114
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile